Variant report
Variant | esv1832272 |
---|---|
Chromosome Location | chr2:57844545-57849628 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13030292 | chr2:57844545-57844546 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs551015322 | chr2:57844570-57844571 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530128545 | chr2:57844584-57844585 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145952668 | chr2:57844615-57844616 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551204311 | chr2:57844632-57844633 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540692364 | chr2:57844651-57844652 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572981784 | chr2:57844670-57844671 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542896576 | chr2:57844680-57844681 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535626338 | chr2:57844729-57844730 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555239753 | chr2:57844731-57844732 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188688117 | chr2:57844751-57844752 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78736324 | chr2:57844785-57844786 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111516754 | chr2:57844810-57844811 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563746361 | chr2:57844825-57844826 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577206645 | chr2:57844859-57844860 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116509735 | chr2:57844871-57844872 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559973870 | chr2:57844947-57844948 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376509062 | chr2:57844957-57844958 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372840255 | chr2:57844977-57844978 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562235256 | chr2:57844991-57844992 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13405187 | chr2:57845015-57845016 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs1405826 | chr2:57845016-57845017 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs114857168 | chr2:57845075-57845076 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370730020 | chr2:57845117-57845118 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533338273 | chr2:57845135-57845136 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376188725 | chr2:57845160-57845161 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566777958 | chr2:57845170-57845171 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181470334 | chr2:57845171-57845172 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148768773 | chr2:57845231-57845232 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568669235 | chr2:57845239-57845240 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs571234960 | chr2:57845310-57845311 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187169059 | chr2:57845321-57845322 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191938480 | chr2:57845328-57845329 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72800618 | chr2:57845396-57845397 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs375024257 | chr2:57845403-57845404 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553455190 | chr2:57845430-57845431 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs367695593 | chr2:57845487-57845488 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573501536 | chr2:57845508-57845509 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1852563 | chr2:57845547-57845548 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs562311041 | chr2:57845551-57845552 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142423858 | chr2:57845592-57845593 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544746836 | chr2:57845627-57845628 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564557617 | chr2:57845663-57845664 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533238501 | chr2:57845759-57845760 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs546997119 | chr2:57845771-57845772 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566708276 | chr2:57845778-57845779 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182227904 | chr2:57845793-57845794 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548853857 | chr2:57845819-57845820 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570146980 | chr2:57845822-57845823 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568755751 | chr2:57845857-57845858 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57844200-57845000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr2:57844400-57844600 | Flanking Active TSS | Fetal Thymus | thymus |
3 | chr2:57844400-57844600 | Flanking Active TSS | Thymus | Thymus |
4 | chr2:57844400-57844800 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr2:57844400-57844800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr2:57844600-57846400 | Active TSS | Fetal Thymus | thymus |
7 | chr2:57844600-57846400 | Active TSS | Thymus | Thymus |
8 | chr2:57846400-57846600 | Enhancers | Fetal Thymus | thymus |
9 | chr2:57846600-57855400 | Weak transcription | Fetal Thymus | thymus |
10 | chr2:57846800-57849600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr2:57848400-57848600 | Enhancers | Brain Germinal Matrix | brain |
12 | chr2:57848400-57849600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr2:57848400-57850000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr2:57848800-57849800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr2:57848800-57850000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr2:57848800-57850000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr2:57848800-57850000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr2:57849000-57849800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr2:57849000-57850000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr2:57849200-57849400 | Enhancers | Brain Germinal Matrix | brain |
21 | chr2:57849200-57849600 | Enhancers | Fetal Heart | heart |
22 | chr2:57849600-57850600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |